K
Kelli M. Robertson
Researcher at Anschutz Medical Campus
Publications - 2
Citations - 45
Kelli M. Robertson is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Aurora inhibitor & In vivo. The author has an hindex of 2, co-authored 2 publications receiving 38 citations.
Papers
More filters
Journal ArticleDOI
Antitumor Activity of the MEK Inhibitor TAK-733 against Melanoma Cell Lines and Patient-Derived Tumor Explants
Lindsey N. Micel,John J. Tentler,Aik Choon Tan,Heather M. Selby,Kelsey L. Brunkow,Kelli M. Robertson,S. Lindsey Davis,Peter J. Klauck,Todd M. Pitts,Esha Gangolli,Robyn Fabrey,Shawn M. O’Connell,Patrick Vincent,S. Gail Eckhardt +13 more
TL;DR: It is demonstrated that TAK-733 exhibits robust tumor growth inhibition and regression against human melanoma cell lines and patient-derived xenograft models, suggesting that further clinical development in melanoma is of scientific interest.
Journal ArticleDOI
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models.
S. Lindsey Davis,Kelli M. Robertson,Todd M. Pitts,John J. Tentler,Erica L. Bradshaw-Pierce,Erica L. Bradshaw-Pierce,Erica L. Bradshaw-Pierce,Peter J. Klauck,Stacey M. Bagby,Stephanie L. Hyatt,Heather M. Selby,Anna Spreafico,Jeffrey Ecsedy,John J. Arcaroli,Wells A. Messersmith,Aik Choon Tan,S. Gail Eckhardt +16 more
TL;DR: In this paper, the combination of an Aurora A kinase and MEK inhibitor was evaluated in pre-clinical colorectal cancer models, with a focus on identifying a subpopulation in which it might be most effective.